Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual
S. Eva Singletary(The University of Texas Health Science Center at Houston), Frederick L. Greene(Memorial Sloan Kettering Cancer Center), Ann D. Thor(University of Colorado Anschutz Medical Campus), Abram Recht(Beth Israel Deaconess Medical Center), Stephen B. Edge(American Society of Clinical Oncology), Lorie L. Hughes(Memorial Sloan Kettering Cancer Center), Patrick I. Borgen(Maimonides Medical Center), R. V. P. Hutter(Memorial Sloan Kettering Cancer Center), Donald L. Weaver(University of Vermont), Daniel F. Hayes(University of Michigan–Ann Arbor), Donald A. Berry(Berry & Associates (United States)), Gary M. Clark(Dana-Farber Brigham Cancer Center), Kirby I. Bland(University of Alabama at Birmingham), David L. Page(Duke University), Craig Allred(Nottingham City Hospital), Pandora Ashley(Memorial Sloan Kettering Cancer Center), H. Samuel Wieand(Memorial Sloan Kettering Cancer Center), Lawrence W. Bassett(Memorial Sloan Kettering Cancer Center), Monica Morrow(Memorial Sloan Kettering Cancer Center), Richard L. Theriault(Memorial Sloan Kettering Cancer Center)
Cited by 293
Related Papers
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
|Journal of Clinical Oncology|2007|3.9k
Risk Factors for Breast Cancer in Women with Proliferative Breast Disease
|New England Journal of Medicine|1985|1.9k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k